2009 年 31 巻 1 号 p. 45-48
In Japan, intravenous thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) was approved in 2005. A drastic reconstruction of the medical service system for acute stroke is therefore urgently needed. We had an opportunity to visit Austin Hospital, Melbourne, which is a representative acute stroke hospital in Australia. We obtained useful information concerning the acute stroke care system, inter-hospital cooperation, and evaluation system for the quality of acute stroke care, during this visit. It appeared that the stroke care system in Australia, where the health-insurance system covers all of the citizens, is similar to that in Japan.